Evidence map›Paper›PMID 40740312›Full record

ArticleBMJ public health2024

Assessing tuberculosis clinical presentation, diagnosis and treatment outcomes among children under 5 years old: results from a cohort of children with presumptive TB in Cameroon and Kenya.

Boris Tchounga, Appolinaire Tiam, Rose Otieno Masaba, Nicole Herrera, Muhamed Mbunka, Stephen Siamba, Andre Pascal Goura, Millicent Ouma, Saint Just Petnga, Boris Tchakounté Youngui and 9 more

Registry-linked trialAbstract read
In one paragraph

Article in BMJ public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03862261 (Integrating Pediatric TB Services Into Child Healthcare Services in Africa. A Cluster-randomized Stepped-wedge Trial), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03862261 nacompletednot on this map

Integrating Pediatric TB Services Into Child Healthcare Services in Africa. A Cluster-randomized Stepped-wedge Trial

TypeinterventionalSponsorElizabeth Glaser Pediatric AIDS FoundationRan2019 to 2021Enrolled1,715ConditionsTuberculosis, Children, Only, Diagnosis, Delivery of Health CareArmsIntegrated pediatric TB services
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Boris TchoungaResearch, Elizabeth Glaser Pediatric AIDS Foundation, Yaoundé, Cameroon.ORCID https://orcid.org/0000-0002-8747-9610
Appolinaire TiamTechnical Strategy and Innovation, Elizabeth Glaser Pediatric AIDS Foundation, Washington, District of Columbia, USA.
Rose Otieno MasabaResearch, Elizabeth Glaser Pediatric AIDS Foundation, Nairobi, Kenya.ORCID https://orcid.org/0000-0003-1801-7938
Nicole HerreraResearch, Elizabeth Glaser Pediatric AIDS Foundation, Washington, District of Columbia, USA.
Muhamed MbunkaResearch, Elizabeth Glaser Pediatric AIDS Foundation, Yaoundé, Cameroon.
Stephen SiambaResearch, Elizabeth Glaser Pediatric AIDS Foundation, Nairobi, Kenya.
Andre Pascal GouraResearch, Elizabeth Glaser Pediatric AIDS Foundation, Yaoundé, Cameroon.
Millicent OumaResearch, Elizabeth Glaser Pediatric AIDS Foundation, Nairobi, Kenya.
Saint Just PetngaResearch, Elizabeth Glaser Pediatric AIDS Foundation, Yaoundé, Cameroon.
Boris Tchakounté YounguiResearch, Elizabeth Glaser Pediatric AIDS Foundation, Yaoundé, Cameroon.ORCID https://orcid.org/0000-0003-1817-4845
Armel ZemsiResearch, Elizabeth Glaser Pediatric AIDS Foundation, Yaoundé, Cameroon.
Anne-Cecile Zoung-Kanyi BissekDivision of Operation Research, Ministry of Public Health, Yaounde, Cameroon.
Gordon OkomoMinistery of Public Health Kenya, Nairobi, Kenya.
Leonie SimoTechnical Strategy and Innovation, Elizabeth Glaser Pediatric AIDS Foundation, Yaoundé, Cameroon.
Martina CasenghiTechnical Strategy and Innovation, Elizabeth Glaser Pediatric AIDS Foundation, Geneva, Switzerland.
Patrice TchendjouResearch, Elizabeth Glaser Pediatric AIDS Foundation, Yaoundé, Cameroon.
John DitekemenaProgram Implementation and Country Management, Elizabeth Glaser Pediatric AIDS Foundation, Kinshasa, Democratic Republic of Congo.
Natella RakhmaninaTechnical Strategy and Innovation, Elizabeth Glaser Pediatric AIDS Foundation, Washington, District of Columbia, USA.
Lise Denoeud-NdamResearch, Elizabeth Glaser Pediatric AIDS Foundation, Geneva, Switzerland.ORCID https://orcid.org/0000-0002-9482-1461

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The majority of paediatric tuberculosis (TB) cases remain undiagnosed or unreported, with only 55% of the estimated 1.25 million paediatric TB cases reported in 2023. We leveraged the INPUT study to characterise the clinical presentations and factors associated with TB diagnosis and treatment success in children under 5 years in Cameroon and Kenya. Method: We conducted a prospective cohort analysis nested in the INPUT study, implemented from May 2019 to June 2021 to assess the integration of paediatric TB services into child healthcare services. All children presenting in participating health facilities, presumed with TB and eligible to the INPUT study, were enrolled and followed up from diagnosis to treatment initiation and completion. We used multivariable logistic regression to explore factors associated with TB diagnosis. Results: Of the 790 children enrolled in the cohort, 458 (58.0%) were aged <2 years; the most frequent suggestive TB symptoms were cough (76.5%), fever (34.9%), night sweats (21.2%), loss of appetite (33.5%) and fatigue (35.9%). Overall, 157 (19.9%) children were diagnosed with TB disease, including 13/157 (8.3%) bacteriologically confirmed and 84/157 (53.5%) with a chest radiography evocative of TB. In multivariable analysis, living in rural area (aOR 1.9; 95% CI (1.1 to 3.5)), presenting with fever >10 days (aOR 1.8; 95% CI (1.1 to 3.1)), having HIV (aOR 3.9; 95% CI (1.7 to 8.9)), presenting with acute malnutrition (aOR 2.8; 95% CI (1.5 to 5.2)), living with someone coughing in the household for more than 2 weeks (aOR 1.8; 95% CI (1.0 to 3.0)) and presenting with peripheral lymphadenitis (aOR 9.5; 95% CI (4.3 to 20.9)) were significantly associated with TB diagnosis in children under 5 years with signs and symptoms suggestive of TB. All children diagnosed with TB were initiated on treatment; 136 (86.6%) achieved treatment success according to WHO definition. Conclusion: In the context of integrated, decentralised evaluation of paediatric TB in the INPUT study, most TB diagnoses in children under 5 years old were made clinically-radiologically. Decentralised strategies enhancing the clinical diagnosis, including repeated capacitation of clinicians to the use of treatment decision algorithms and increased access to chest radiography, could overcome underdiagnosis of paediatric TB. Trial registration number: NCT03862261.

Indexed as

Epidemiologic FactorsEpidemiologic Study CharacteristicsSociodemographic Factors

Identifiers

PMID40740312
PMCPMC12308155

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.